AET Laboratories Private Limited: Clinical Trials

3 completed. 3 Not applicable.

By phase and status

Phase	Trials	Status
Not applicable	3	Completed 3

Follow AET Laboratories Private Limited: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
The Study Aims to Show Bioequivalence of the Test Product and the Reference Reference Product in a Crossover Design Study Healthy Volunteers. Additionally, the Safety Profile of Test Product Compared to Reference Product Will be Assessed. Metformin and Vildagliptin 850/50 mg - To Determine Bioequivalence Under Fed Conditions	Not applicable	Completed	AET Laboratories Private Limited	60	2015-12-01	2022-04-20
The Study Intends to Show Bioequivalence of the Test Product and the Reference Reference Product in a Crossover Design Study Healthy Volunteers. Additionally, the Safety Profile of Test Product Compared to Reference Product Will be Evaluated. Metformin and Vildagliptin 1000/50 mg - To Determine Bioequivalence Under Fed Conditions	Not applicable	Completed	AET Laboratories Private Limited	60	2015-12-01	2022-04-15
The Study Aims to Show Bioequivalence of the Test Product and the Reference Reference Product in a Crossover Design Study Healthy Volunteers. Additionally, the Safeyt Profile of Test Product Compared to Reference Product Will be Assessed. Vildagliptin 50 MG - Diabetes Mellitus	Not applicable	Completed	AET Laboratories Private Limited	66	2014-02-01	2022-04-15

Conditions studied

Diabetes Mellitus (1)

Interventions

Vildagliptin (3)  ·  Metformin (2)